Clinical Trials Browser

Phase 2/3 × Completed × Bortezomib × Clear all

NCT00861250 2016-06-17

Assessment of Molecular Remission by ASO-qPCR After Bortezomib-dexamethasone (Vel/Dex) Followed by ASCT

Phase 2/3 Completed

Multiple Myeloma

NCT00514371 2015-12-07

TIME-2

Phase 2/3 Completed

Multiple Myeloma